The history of Sildenafil presents a challenging picture for shareholders. While the initial introduction generated substantial profits, the end of its patent opened the door to generic alternatives, dramatically diminishing market share. This presents a specific challenge for pharmaceutical comp

The emergence of so-called "Elite Gambler's Sildenafil" – often referring to exceptionally high doses administered by unscrupulous physicians – represents a troublingly alarming trend. While typical dosages of the medication are intended for treating erectile dysfunction safely in most patients,